|
Nutri Pharma ASA - Company Profile Snapshot
| Company Profile: |
Nutri Pharma ASA |
| Ticker: |
NUT |
| Exchanges: |
OSL |
| 2008 Sales: |
98,441,000 |
| Major Industry: |
Food & Beverages |
| Sub Industry: |
Miscellaneous Food |
| Country: |
NORWAY |
| Employees: |
6 |
Business Description
Nutri Pharma ASA. The Group's principal activity is to develop products that beneficially influence lifestyle related disorders. The lifestyle related diseases are obesity, hyperlipidaemia and type 2 diabetes. The Group develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The soy technology prevents the development of life style related diseases such as obesity, elevated cholesterol levels and type 2 diabetes. The Group operates in two segments: Royalty and Direct Sales. Products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment).
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
